The Human Biomedical Research Act (HBRA) of Singapore regulates all research that involves human biospecimen in Singapore. Institutions or individuals aiming to establish a biobank under SingHealth must adopt best practices from established biobanks and ISBER. Recently, the team from SingHealth published a poster explaining the “Best Practices for Establishing a Biobank in Singapore Research Institution.” Stages […]
The Winship Cancer Institute Clinical Trial office (CTO) conducts high-quality clinical trials involving cancer patients. It conducts over 250 clinical trials enrolling roughly 800 patients per year. In May 2016, they adopted OpenSpecimen as their biobanking LIMS to manage their biospecimens due to its highly configurable features including REST APIs to integrate with . Refer to […]
This month in 1792, the US Postal Service was created! Postage cost between 6 and 25 cents, depending on the distance your parcel needed to travel! The Postal Service Act, signed by George Washington on February 20th, transformed the Constitutional Post, a fledgling mail delivery service run by Benjamin Franklin, into an official department of […]
Here is your monthly curated pick of biobanking news, jobs, and events from across the globe. Fresh of the Press Australian biobank repatriates hundreds of ‘legacy’ Indigenous blood samples Clinical trials planned for brain tumor ‘GPS’ maps at Case Western Reserve University Geisinger’s biobank surpasses 250,000 patients NIH establishes Infectious Diseases Clinical Research Consortium AI shows promise for breast cancer […]
What do you plan to do for the holidays? Meet family, vacation, foreign trip, or my favorite- “do nothing”? Do let us know or better send us some pictures. Before you go, here is your monthly curated pick of biobanking news, jobs, and events from across the globe. Fresh of the Press: NIH launches first […]
The short answer is Yes. However, it is important to note that the software itself cannot be compliant. Rather, it is the implementation and use of software that determines compliance. It is achieved only when a study has the procedures, policies, documentation, training, and validation that meets Part-11 requirements. An FDA auditor will review all […]
I read an article recently about why once in a while “doing nothing” is important and that is why Christmas is my favorite time. Better than Diwali or any of the other 100s of festivals we Indians observe. Simply because you all, my dear customers, will be away. That too, all at the same time! It […]
Managing biospecimen data for longitudinal studies or clinical trials can be challenging. Clinical studies often go on for months or years, and involves complex workflows like kit preparations, tracking upcoming visits, multi-site collections, shipments, and so forth. To manage these types of collections, OpenSpecimen offers a customizable platform to plan, manage and track biospecimens in a […]
The long-term sustainability of biobanks has been a major concern. “Sustainability is [a biobank’s] capacity to remain operative, effective, and competitive over its expected lifetime.” OECD Global Science Forum 2017 BBMRI-NL has made a Series on Sustainable Biobanking, combining current knowledge from literature, workshops, and focus groups. The Series contains an infographic with nine recommendations […]
This case study describes the adoption of OpenSpecimen at one of the biggest biobanks in gastroenterology (GI) cancer in an academic center in Pittsburgh. Prior to OpenSpecimen, they used an in-house system to store clinical and specimen data. However, it had several shortcomings which were severely impeding their ability to find specimens of research interest. […]
